OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India
Samir Joshi, Rahul Ashok Telang, Muralidhar Tambe, et al.
Emerging infectious diseases (2021) Vol. 28, Iss. 1, pp. 1-8
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 27

Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review
Kasim Allel, María José Hernández, Nichola R. Naylor, et al.
BMJ Global Health (2024) Vol. 9, Iss. 2, pp. e013205-e013205
Open Access | Times Cited: 7

Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections
David Pham, Annaleise R. Howard‐Jones, Rebecca Sparks, et al.
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 659-659
Open Access | Times Cited: 13

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
Cornelius J. Clancy, M. Hong Nguyen
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 12

Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An In Silico Statement
Supriyo Saha, Gyu Seong Yeom, Satish Balasaheb Nimse, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 11

Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study
Aanchal Satija, Tanu Anand, Aparna Mukherjee, et al.
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 745-753
Closed Access | Times Cited: 5

The interplay of co-infections in shaping COVID-19 severity: Expanding the scope beyond SARS-CoV-2
Budhadev Baral, Vaishali Saini, Meenakshi Kandpal, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 8, pp. 102486-102486
Closed Access | Times Cited: 1

Outcomes of different steroid dosing regimens in critical Covid-19 pneumonia at a Kenyan hospital: A retrospective cohort study
John Otieno Odhiambo, Jasmit Shah, Nancy Kunyiha, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0307265-e0307265
Open Access | Times Cited: 1

Impact of inappropriate empirical antibiotic therapy on in-hospital mortality: a retrospective multicentre cohort study of patients with bloodstream infections in Chile, 2018–2022
Kasim Allel, Anne Peters, Luis Furuya‐Kanamori, et al.
BMJ Public Health (2024) Vol. 2, Iss. 2, pp. e001289-e001289
Open Access | Times Cited: 1

Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
Maria Panagiota Almyroudi, Karolina Akinosoglou, Jordi Rello, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3092-3092
Open Access | Times Cited: 8

Increasing Incidence of mucormycosis in Spanish inpatients from 1997 to 2018
Raúl Parra Fariñas, Montserrat Alonso‐Sardón, Virgínia Velasco-Tirado, et al.
Mycoses (2021) Vol. 65, Iss. 3, pp. 344-353
Closed Access | Times Cited: 10

Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review
Pragati Upadhayay, Keshav Bansal, Ahsas Goyal
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1645-1656
Closed Access | Times Cited: 3

Combating Black Fungus: Using Allicin as a Potent Antifungal Agent against Mucorales
Christina Schier, Martin C. H. Gruhlke, Georg Reucher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17519-17519
Open Access | Times Cited: 2

Radiographic and Clinical Analysis of Cranio-Maxillofacial Complications of Cavernous Sinus Thrombosis Among 256 COVID-19 Patients
Boymuradov A. Shukhrat, Najla Dar‐Odeh, Bobamuratova T. Dilnoza, et al.
Journal of Craniofacial Surgery (2022) Vol. 33, Iss. 5, pp. 1549-1553
Open Access | Times Cited: 4

Pediatric cutaneous mucormicosis
Mariana Claudia Matei, Sandra Castejón-Ramírez, Sara Sanz Sanz, et al.
Dermatology Online Journal (2024) Vol. 29, Iss. 6
Open Access

Outcomes of COVID‐19‐associated mucormycosis epidemic in India: A prospective 2‐year follow‐up study
Vishav Yadav, Sanjeev Bhagat, Khushboo Goel, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery (2024) Vol. 11, Iss. 1, pp. 66-73
Open Access

Mutational landscape and emerging variants of SARS-CoV-2
Sarah Hamid, Mohammad “Sufian” Badar, Mohammad Manzoor Alam, et al.
Elsevier eBooks (2024), pp. 181-210
Closed Access

Utility of intraoperative scoring system in rhino-orbital mucormycosis as a prognostic tool
Neehal Zuturu, Vijendra Shenoy, Sanchit Bajpai, et al.
Acta Otorhinolaryngologica Italica (2024) Vol. 44, Iss. 5, pp. 313-321
Open Access

Covid-19 of the Ears, Nose, Throat, and Sinuses
Rachel Mittelstaedt, Miriam B. Barshak
(2024), pp. 471-485
Closed Access

Az orrmelléküregek mucormycosisa
Zoltán Iszlai, Emőke Kiss-Tóth, Tamás Karosi
Orvosi Hetilap (2024) Vol. 165, Iss. 48, pp. 1878-1887
Open Access

A Study on the Involvement of Facial Bones in Mucormycosis Patients
Shankar Ganesh
Indian Journal of Otolaryngology and Head & Neck Surgery (2024) Vol. 76, Iss. 5, pp. 4222-4229
Closed Access

Role of myeloid-derived suppressor and Th17/Treg cells in post-COVID-19 Rhino-Orbital mucormycosis cases
Praveen Kumar Singh, Gargi Rai, Shukla Das, et al.
Immunopharmacology and Immunotoxicology (2024), pp. 1-7
Closed Access

Sinonasal mucormycosis during 2 years of COVID-19 pandemic in central Iran: incidence rate and clinical features
Mohammad Hossein Dadgarnia, Mohammad Mandegari, Mohammadhossein Baradaranfar, et al.
Acta Otorrinolaringológica Española (2023) Vol. 74, Iss. 5, pp. 298-304
Closed Access | Times Cited: 1

Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis
Sulena Sulena, Munish Dhawan, Navchint Singh, et al.
Journal of Neurosciences in Rural Practice (2022) Vol. 13, pp. 730-739
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top